178 related articles for article (PubMed ID: 14742907)
21. Pre-plaque conformational changes in Alzheimer's disease-linked Aβ and APP.
Klementieva O; Willén K; Martinsson I; Israelsson B; Engdahl A; Cladera J; Uvdal P; Gouras GK
Nat Commun; 2017 Mar; 8():14726. PubMed ID: 28287086
[TBL] [Abstract][Full Text] [Related]
22. Gd-nanoparticles functionalization with specific peptides for ß-amyloid plaques targeting.
Plissonneau M; Pansieri J; Heinrich-Balard L; Morfin JF; Stransky-Heilkron N; Rivory P; Mowat P; Dumoulin M; Cohen R; Allémann É; Tόth É; Saraiva MJ; Louis C; Tillement O; Forge V; Lux F; Marquette C
J Nanobiotechnology; 2016 Jul; 14(1):60. PubMed ID: 27455834
[TBL] [Abstract][Full Text] [Related]
23. Decoding the synaptic dysfunction of bioactive human AD brain soluble Aβ to inspire novel therapeutic avenues for Alzheimer's disease.
Li S; Jin M; Liu L; Dang Y; Ostaszewski BL; Selkoe DJ
Acta Neuropathol Commun; 2018 Nov; 6(1):121. PubMed ID: 30409172
[TBL] [Abstract][Full Text] [Related]
24. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters.
Matsuzaki K
Acc Chem Res; 2014 Aug; 47(8):2397-404. PubMed ID: 25029558
[TBL] [Abstract][Full Text] [Related]
25. Modulating amyloid-β aggregation: The effects of peptoid side chain placement and chirality.
Turner JP; Chastain SE; Park D; Moss MA; Servoss SL
Bioorg Med Chem; 2017 Jan; 25(1):20-26. PubMed ID: 27776890
[TBL] [Abstract][Full Text] [Related]
26. Diminished parkin solubility and co-localization with intraneuronal amyloid-β are associated with autophagic defects in Alzheimer's disease.
Lonskaya I; Shekoyan AR; Hebron ML; Desforges N; Algarzae NK; Moussa CE
J Alzheimers Dis; 2013; 33(1):231-47. PubMed ID: 22954671
[TBL] [Abstract][Full Text] [Related]
27. Cytoplasmic gelsolin increases mitochondrial activity and reduces Abeta burden in a mouse model of Alzheimer's disease.
Antequera D; Vargas T; Ugalde C; Spuch C; Molina JA; Ferrer I; Bermejo-Pareja F; Carro E
Neurobiol Dis; 2009 Oct; 36(1):42-50. PubMed ID: 19607917
[TBL] [Abstract][Full Text] [Related]
28. Molecular studies on Abeta(42) induced genomic instability in aged rabbit brain.
Narasingappa RB; Prahalad RK; Mannar SS; Sathyanarayana RT; Hanumanthappa BK; Jagannatha RK
Neurochem Int; 2010 Apr; 56(5):655-62. PubMed ID: 20117159
[TBL] [Abstract][Full Text] [Related]
29. Icariin inhibits beta-amyloid peptide segment 25-35 induced expression of beta-secretase in rat hippocampus.
Nie J; Luo Y; Huang XN; Gong QH; Wu Q; Shi JS
Eur J Pharmacol; 2010 Jan; 626(2-3):213-8. PubMed ID: 19782061
[TBL] [Abstract][Full Text] [Related]
30. Chemical modifications of amyloid-β(1-42) have a significant impact on the repertoire of brain amyloid-β(1-42) binding proteins.
Medvedev AE; Buneeva OA; Kopylov AT; Mitkevich VA; Kozin SA; Zgoda VG; Makarov AA
Biochimie; 2016; 128-129():55-8. PubMed ID: 27400251
[TBL] [Abstract][Full Text] [Related]
31. Structure-function implications in Alzheimer's disease: effect of Abeta oligomers at central synapses.
Cerpa W; Dinamarca MC; Inestrosa NC
Curr Alzheimer Res; 2008 Jun; 5(3):233-43. PubMed ID: 18537540
[TBL] [Abstract][Full Text] [Related]
32. Endogenous polyamines reduce the toxicity of soluble aβ peptide aggregates associated with Alzheimer's disease.
Luo J; Mohammed I; Wärmländer SK; Hiruma Y; Gräslund A; Abrahams JP
Biomacromolecules; 2014 Jun; 15(6):1985-91. PubMed ID: 24750033
[TBL] [Abstract][Full Text] [Related]
33. Heat-induced DNA relaxation in vitro by mouse DNA topoisomerase I in the presence of ethidium bromide.
Haq S; Natori S; Sekimizu K
J Biochem; 1993 May; 113(5):620-4. PubMed ID: 8393438
[TBL] [Abstract][Full Text] [Related]
34. Methionine residue 35 is critical for the oxidative stress and neurotoxic properties of Alzheimer's amyloid beta-peptide 1-42.
Butterfield DA; Kanski J
Peptides; 2002 Jul; 23(7):1299-309. PubMed ID: 12128086
[TBL] [Abstract][Full Text] [Related]
35. β-Amyloid-aluminum complex alters cytoskeletal stability and increases ROS production in cortical neurons.
Bolognin S; Zatta P; Lorenzetto E; Valenti MT; Buffelli M
Neurochem Int; 2013 Apr; 62(5):566-74. PubMed ID: 23416043
[TBL] [Abstract][Full Text] [Related]
36. Copper(I) and copper(II) inhibit Aβ peptides proteolysis by insulin-degrading enzyme differently: implications for metallostasis alteration in Alzheimer's disease.
Grasso G; Pietropaolo A; Spoto G; Pappalardo G; Tundo GR; Ciaccio C; Coletta M; Rizzarelli E
Chemistry; 2011 Feb; 17(9):2752-62. PubMed ID: 21274957
[TBL] [Abstract][Full Text] [Related]
37. Intracellular accumulation of beta-amyloid(1-42) in neurons is facilitated by the alpha 7 nicotinic acetylcholine receptor in Alzheimer's disease.
Nagele RG; D'Andrea MR; Anderson WJ; Wang HY
Neuroscience; 2002; 110(2):199-211. PubMed ID: 11958863
[TBL] [Abstract][Full Text] [Related]
38. N-Terminal Hypothesis for Alzheimer's Disease.
Murray B; Sharma B; Belfort G
ACS Chem Neurosci; 2017 Mar; 8(3):432-434. PubMed ID: 28186729
[TBL] [Abstract][Full Text] [Related]
39. Alzheimer's disease: soluble oligomeric Abeta(1-40) peptide in membrane mimic environment from solution NMR and circular dichroism studies.
Mandal PK; Pettegrew JW
Neurochem Res; 2004 Dec; 29(12):2267-72. PubMed ID: 15672549
[TBL] [Abstract][Full Text] [Related]
40. In vivo SPECT imaging of amyloid-β deposition with radioiodinated imidazo[1,2-a]pyridine derivative DRM106 in a mouse model of Alzheimer's disease.
Chen CJ; Bando K; Ashino H; Taguchi K; Shiraishi H; Shima K; Fujimoto O; Kitamura C; Matsushima S; Uchida K; Nakahara Y; Kasahara H; Minamizawa T; Jiang C; Zhang MR; Ono M; Tokunaga M; Suhara T; Higuchi M; Yamada K; Ji B
J Nucl Med; 2015 Jan; 56(1):120-6. PubMed ID: 25476539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
